We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$7.65B
AUM Growth
-$2.07B
Cap. Flow
-$890M
Cap. Flow %
-11.64%
Top 10 Hldgs %
69.25%
Holding
109
New
20
Increased
5
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ONON icon
On Holding
ONON
+$561M
2
LEGN icon
Legend Biotech
LEGN
+$433M
3
CTKB icon
Cytek Biosciences
CTKB
+$206M
4
SE icon
Sea Limited
SE
+$101M
5
ERAS icon
Erasca
ERAS
+$97.4M

Top Sells

Rank Stock Value
1
ESGR
Enstar Group
ESGR
+$418M
2
PDD icon
Pinduoduo
PDD
+$398M
3
ZM icon
Zoom
ZM
+$398M
4
ABNB icon
Airbnb
ABNB
+$300M
5
UBER icon
Uber
UBER
+$188M

Sector Composition

Rank Sector Weight
1 Healthcare 57.57%
2 Consumer Discretionary 24.98%
3 Technology 6.63%
4 Communication Services 6.51%
5 Consumer Staples 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVET
76
DELISTED
Covetrus, Inc. Common Stock
CVET
$2.81M 0.04%
155,124
DNUT icon
77
Krispy Kreme
DNUT
$560M
$2.63M 0.03%
+188,638
New +$3.03M
CDAK
78
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2.33M 0.03%
142,978
-223,743
-61% -$4M
CCC
79
CCC Intelligent Solutions
CCC
$3.64B
$2.1M 0.03%
+200,000
New +$2.07M
SFUN
80
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$2.06M 0.03%
327,720
YSG
81
Yatsen Holding
YSG
$315M
$955K 0.01%
50,153
LEAP.U
82
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$523K 0.01%
50,000
SRZNW icon
83
Surrozen Inc Warrant
SRZNW
$36.6K
$456K 0.01%
+399,999
New +$550K
CIH
84
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$438K 0.01%
300,000
CCCS.WS
85
DELISTED
CCC Intelligent Solutions Holdings Inc. Redeemable warrants, each whole warrant exercisable for one
CCCS.WS
$93K ﹤0.01%
+40,000
New +$96.7K
AAPL icon
86
Apple
AAPL
$4.99T
-200,000
Closed -$27.4M
APLS
87
DELISTED
Apellis Pharmaceuticals
APLS
-2,929,708
Closed -$185M
AXSM icon
88
Axsome Therapeutics
AXSM
$11.9B
-360,000
Closed -$24.3M
BPMC
89
DELISTED
Blueprint Medicines
BPMC
-635,302
Closed -$55.9M
COGT icon
90
Cogent Biosciences
COGT
$6.82B
-1,000,000
Closed -$8.11M
EDU icon
91
New Oriental
EDU
$9.13B
-7,877
Closed -$645K
ESGR
92
DELISTED
Enstar Group
ESGR
-1,747,840
Closed -$418M
KYNB
93
Kyntra Bio
KYNB
$28.2M
-158,231
Closed -$105M
GDS icon
94
GDS Holdings
GDS
$5.92B
-390,000
Closed -$30.6M
HOOK
95
DELISTED
HOOKIPA Pharma
HOOK
-26,937
Closed -$2.47M
IGMS
96
DELISTED
IGM Biosciences
IGMS
-151,390
Closed -$12.6M
KOD icon
97
Kodiak Sciences
KOD
$2.44B
-810,207
Closed -$75.3M
KURA icon
98
Kura Oncology
KURA
$795M
-650,000
Closed -$13.6M
CYPH
99
Cypherpunk Technologies Inc
CYPH
$64.3M
-357,575
Closed -$5.86M
NKTX icon
100
Nkarta
NKTX
$155M
-277,778
Closed -$8.8M

Similar funds

HHLR Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, HHLR Advisors held 109 positions worth $7.65B, down 21% from $9.71B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HHLR Advisors withdrew a net $890M in Q3 2021, closing 24 positions and reducing 15 holdings. Its most notable exit was Enstar Group, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in On Holding worth $481M.

  • HHLR Advisors's largest Q3 2021 buy was On Holding: 15,973,750 shares worth $481M.
  • HHLR Advisors added most to Legend Biotech in Q3 2021, an estimated $433M increase.
  • HHLR Advisors's biggest Q3 2021 reduction was Pinduoduo, cutting an estimated $398M.
  • HHLR Advisors fully exited Enstar Group in Q3 2021, selling an estimated $418M.
  • HHLR Advisors's ten largest holdings make up 69% of its $7.65B portfolio in Q3 2021.
  • HHLR Advisors opened 20 new positions and closed 24 in Q3 2021.
  • HHLR Advisors's portfolio value fell 21% quarter-over-quarter to $7.65B.

Based on HHLR Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.